Ortho-Clinical and Quotient Strike $69M Deal for Blood Transfusion Test
Saturday, February 7, 2015
Source: Fierce Diagnostics
Ortho-Clinical Diagnostics has signed an exclusive deal worth up to $69 million with commercial-stage company Quotient to distribute and sell a blood transfusion diagnostics platform in development.
The Quotient platform, dubbed MosaiQ, aims to shorten the time it takes to get test results and to offer more comprehensive matching of donor and patient blood than currently available transfusion diagnostic instruments.